Stay updated on Subcutaneous Nivolumab + rHuPH20 Clinical Trial

Sign up to get notified when there's something new on the Subcutaneous Nivolumab + rHuPH20 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Subcutaneous Nivolumab + rHuPH20 Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    Added a new PubMed publication entry (CheckMate 8KX pharmacokinetics/safety study) to the Publications section; no deletions or core-content changes detected.
    Difference
    3%
    Check dated 2025-10-13T12:33:04.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    Summary of changes: updated operating status notice and version to v3.2.0, replacing the previous v3.1.0.
    Difference
    3%
    Check dated 2025-10-06T08:27:06.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    - The page now shows a new revision: v3.1.0 in place of v3.0.2. This indicates a release/version update.
    Difference
    0.1%
    Check dated 2025-09-29T05:15:42.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    Version bumped from v3.0.1 to v3.0.2; the 'Back to Top' link was removed.
    Difference
    0.2%
    Check dated 2025-09-14T23:30:50.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.
    Difference
    0.2%
    Check dated 2025-09-07T20:18:56.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of new facility names and locations across various countries, as well as the introduction of new medical terms related to proteins and antibodies. The revision number has also been updated to v3.0.0.
    Difference
    3%
    Check dated 2025-08-31T12:45:37.000Z thumbnail image

Stay in the know with updates to Subcutaneous Nivolumab + rHuPH20 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Subcutaneous Nivolumab + rHuPH20 Clinical Trial page.